| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Geffner Michael is a Chief Medical Officer at Immunovant, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $6.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 2,595 | $19.03 | $49,382.85 | -1.2% | +38.3% | - | |
| Oct 8, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 1,272 | $16.30 | $20,733.60 | -0.6% | +61.1% | - | |
| Jul 23, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 2,385 | $18.15 | $43,287.75 | -1.1% | +4.6% | - | |
| Jul 9, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 1,160 | $17.24 | $19,998.40 | -0.5% | -6.8% | - | |
| Apr 23, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 2,349 | $14.79 | $34,741.71 | -1.0% | +24.2% | - | |
| Apr 9, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 6,169 | $12.99 | $80,135.31 | -2.6% | +13.4% | +72.1% | |
| Jan 22, 2025 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 2,657 | $23.59 | $62,678.63 | -2.0% | -38.7% | +12.7% | |
| Oct 23, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 3,189 | $29.53 | $94,171.17 | -2.3% | -21.4% | -37.6% | |
| Jul 24, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 3,456 | $27.76 | $95,938.56 | -2.4% | +5.9% | -34.4% | |
| Apr 24, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 3,261 | $28.90 | $94,242.90 | -2.3% | -2.8% | -47.7% |